RIANA: Viennese start-up develops novel, precise anti-cancer drugs

We are delighted to announce the incorporation of RIANA Therapeutics GmbH, a biotech startup focused on developing novel anti-cancer treatments. RIANA Therapeutics is a spinoff from Vetmeduni, devoted to discovering and developing innovative medicines. RIANA founders Richard Moriggl, Oliver Szolar, VetWidi, and Anna Orlova are very enthusiastic about committing to improving treatments for cancer patients. We are currently in the process of setting up research and development operations in Vienna and will keep you updated. See the full press release by Vetmeduni below: